Umezawa N et al.Interleukin-23 as a therapeutic target for inflammatory myopathy.Sci Rep 8:5498 (2018).
Karaboga I et al.Investigation of the relationship between the Th17/IL-23 pathway and innate-adaptive immune system in TNBS-induced colitis in rats.Iran J Basic Med Sci 20:870-879 (2017).
Jiang H et al.Interleukin-23 may contribute to the pathogenesis of lumbar disc herniation through the IL-23/IL-17 pathway.J Orthop Surg Res 11:12 (2016).
Zhang HJ et al.Effects of curcumin on interleukin-23 and interleukin-17 expression in rat retina after retinal ischemia-reperfusion injury.Int J Clin Exp Pathol 8:9223-31 (2015).
Szkandera J et al.A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.Clin Cancer Res 20:1687-97 (2014).
Helbling M et al.Investigation of IL-23 (p19, p40) and IL-23R identifies nuclear expression of IL-23 p19 as a favorable prognostic factor in colorectal cancer: a retrospective multicenter study of 675 patients.Oncotarget 5:4671-82 (2014).